142 related articles for article (PubMed ID: 22785138)
1. Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes.
Shigematsu E; Yamakawa T; Taguri M; Morita S; Tokui M; Miyamoto K; Funae O; Takatuka Y; Kadonosono K; Shigematsu H; Terauchi Y
J Atheroscler Thromb; 2012; 19(9):846-53. PubMed ID: 22785138
[TBL] [Abstract][Full Text] [Related]
2. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe effectively lowers LDL-cholesterol in cardiac allograft recipients on stable statin therapy.
Konstandin MH; Blessing E; Doesch A; Ammon K; Koch A; Wabnitz GH; Gleissner CA; Remppis A; Katus HA; Dengler TJ
Clin Transplant; 2008; 22(5):639-44. PubMed ID: 18492070
[TBL] [Abstract][Full Text] [Related]
4. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.
Morrone D; Weintraub WS; Toth PP; Hanson ME; Lowe RS; Lin J; Shah AK; Tershakovec AM
Atherosclerosis; 2012 Aug; 223(2):251-61. PubMed ID: 22410123
[TBL] [Abstract][Full Text] [Related]
5. Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.
Guyton JR; Betteridge DJ; Farnier M; Leiter LA; Lin J; Shah A; Johnson-Levonas AO; Brudi P
Diab Vasc Dis Res; 2011 Apr; 8(2):160-72. PubMed ID: 21562068
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitus.
Ciriacks K; Coly G; Krishnaswami S; Patel SB; Kidambi S
Metab Syndr Relat Disord; 2015 Mar; 13(2):84-90. PubMed ID: 25490061
[TBL] [Abstract][Full Text] [Related]
7. RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.
Inazawa T; Sakamoto K; Kohro T; Iijima R; Kitazawa T; Hirano T; Kawamura M; Tagami M; Tanaka A; Mori Y; Yamazaki T; Shiba T;
Lipids Health Dis; 2013 Oct; 12():142. PubMed ID: 24094079
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Gazzara RA; Brady WE; Palmisano J
Mayo Clin Proc; 2006 Sep; 81(9):1177-85. PubMed ID: 16970214
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.
Bissonnette S; Habib R; Sampalis F; Boukas S; Sampalis JS;
Can J Cardiol; 2006 Oct; 22(12):1035-44. PubMed ID: 17036098
[TBL] [Abstract][Full Text] [Related]
10. Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice study.
Fras Z; Mikhailidis DP
Curr Med Res Opin; 2008 Sep; 24(9):2467-76. PubMed ID: 18655751
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.
Yu M; Liang C; Kong Q; Wang Y; Li M
Lipids Health Dis; 2020 Jan; 19(1):1. PubMed ID: 31900179
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
Okada K; Yagyu H; Kotani K; Miyamoto M; Osuga J; Nagasaka S; Ishibashi S
Endocr J; 2010; 57(10):903-8. PubMed ID: 20733267
[TBL] [Abstract][Full Text] [Related]
14. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome.
Denke M; Pearson T; McBride P; Gazzara RA; Brady WE; Tershakovec AM
Diab Vasc Dis Res; 2006 Sep; 3(2):93-102. PubMed ID: 17058629
[TBL] [Abstract][Full Text] [Related]
16. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.
Mikhailidis DP; Sibbring GC; Ballantyne CM; Davies GM; Catapano AL
Curr Med Res Opin; 2007 Aug; 23(8):2009-26. PubMed ID: 17659159
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.
Mikhailidis DP; Lawson RW; McCormick AL; Sibbring GC; Tershakovec AM; Davies GM; Tunceli K
Curr Med Res Opin; 2011 Jun; 27(6):1191-210. PubMed ID: 21473671
[TBL] [Abstract][Full Text] [Related]
19. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial.
Yu CC; Lai WT; Shih KC; Lin TH; Lu CH; Lai HJ; Hanson ME; Hwang JJ
BMC Res Notes; 2012 May; 5():251. PubMed ID: 22621316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
